Log in

ASX:PKSPKS Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally. The company offers RippleDown Expert, an CDS system that provides real-time patient monitoring, alerting, data mining, and reporting capability; and RippleDown Auditor, a knowledge based system that allows various departments within a laboratory, including data entry, billing, and specimen reception to audit data in real-time. It serves customers through direct sales and channel partners. The company was formerly known as QPro Holdings Limited. PKS Holdings Limited was founded in 1996 and is based in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8072 1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.20 million
Book ValueA$0.17 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PKS News and Ratings via Email

Sign-up to receive the latest news and ratings for PKS and its competitors with MarketBeat's FREE daily newsletter.

PKS (ASX:PKS) Frequently Asked Questions

Has PKS been receiving favorable news coverage?

Media stories about PKS stock have been trending very negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. PKS earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutPKS.

Who are some of PKS's key competitors?

Who are PKS's key executives?

PKS's management team includes the following people:
  • Mr. Ronald Andre Van Der Pluijm, MD, CEO & Director
  • Mr. Andrew William Bursill C.A., B.Agr.Ec., CA, Chief Financial Officer (Age 49)
  • Dr. Lindsay Peters, Chief Technical Officer
  • Mr. Michael Reakes, Gen. Mang.
  • Ms. Maggie Niewidok, Company Sec.

What is PKS's stock symbol?

PKS trades on the ASX under the ticker symbol "PKS."

How big of a company is PKS?

PKS has a market capitalization of $0.00 and generates $2.20 million in revenue each year.

What is PKS's official website?

The official website for PKS is www.pks.com.au.

How can I contact PKS?

The company can be reached via phone at 61 2 8072 1400.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.